Ibañez D - Search Results

1

Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes.

Al Maimouni H, Gladman DD, Ibañez D, Urowitz MB. Al Maimouni H, et al. Among authors: ibanez d. Arthritis Care Res (Hoboken). 2014 Dec;66(12):1905-9. doi: 10.1002/acr.22364. Arthritis Care Res (Hoboken). 2014. PMID: 24821661

2

Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus.

Rahman P, Gladman DD, Ibanez D, Urowitz MB. Rahman P, et al. Among authors: ibanez d. Lupus. 2001;10(6):418-23. doi: 10.1191/096120301678646164. Lupus. 2001. PMID: 11434577

3

Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus.

Gladman DD, Chaudhry-Ahluwalia V, Ibañez D, Bogoch E, Urowitz MB. Gladman DD, et al. Among authors: ibanez d. J Rheumatol. 2001 Oct;28(10):2226-9. J Rheumatol. 2001. PMID: 11669161

4

Systemic lupus erythematosus disease activity index 2000.

Gladman DD, Ibañez D, Urowitz MB. Gladman DD, et al. Among authors: ibanez d. J Rheumatol. 2002 Feb;29(2):288-91. J Rheumatol. 2002. PMID: 11838846

5

The nature and outcome of infection in systemic lupus erythematosus.

Gladman DD, Hussain F, Ibañez D, Urowitz MB. Gladman DD, et al. Among authors: ibanez d. Lupus. 2002;11(4):234-9. doi: 10.1191/0961203302lu170oa. Lupus. 2002. PMID: 12043887

6

Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities.

Bruce IN, Gladman DD, Ibañez D, Urowitz MB. Bruce IN, et al. Among authors: ibanez d. J Rheumatol. 2003 Feb;30(2):288-91. J Rheumatol. 2003. PMID: 12563682

7

The impact of the 1997 update of the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus: what has been changed?

Feletar M, Ibañez D, Urowitz MB, Gladman DD. Feletar M, et al. Among authors: ibanez d. Arthritis Rheum. 2003 Jul;48(7):2067-9. doi: 10.1002/art.11167. Arthritis Rheum. 2003. PMID: 12847702 No abstract available.

8

Accrual of organ damage over time in patients with systemic lupus erythematosus.

Gladman DD, Urowitz MB, Rahman P, Ibañez D, Tam LS. Gladman DD, et al. Among authors: ibanez d. J Rheumatol. 2003 Sep;30(9):1955-9. J Rheumatol. 2003. PMID: 12966597

9

Clinically active serologically quiescent systemic lupus erythematosus.

Gladman DD, Hirani N, Ibañez D, Urowitz MB. Gladman DD, et al. Among authors: ibanez d. J Rheumatol. 2003 Sep;30(9):1960-2. J Rheumatol. 2003. PMID: 12966598

10

Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus.

Ibañez D, Urowitz MB, Gladman DD. Ibañez D, et al. J Rheumatol. 2003 Sep;30(9):1977-82. J Rheumatol. 2003. PMID: 12966601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results